Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | STAT3 | P40763 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bisabolone SCHEMBL159878 | 1.00 | LMNA (0.57) | LMNAALOX15CYP3A4STAT3MEN1 | |
| Bisabolone SCHEMBL83912 | 1.00 | LMNA (0.57) | LMNAALOX15CYP3A4STAT3MEN1 | |
| SCHEMBL11575262 | 0.95 | LMNA (0.51) | LMNAALOX15CYP3A4STAT3MEN1 | |
| SCHEMBL11575263 | 0.95 | LMNA (0.51) | LMNAALOX15CYP3A4STAT3MEN1 | |
| SCHEMBL29618988 | 0.87 | LMNA (0.53) | LMNAALOX15CYP3A4STAT3MEN1 | |
| SCHEMBL29388335 | 0.87 | LMNA (0.53) | LMNAALOX15CYP3A4STAT3MEN1 | |
| SCHEMBL3826218 | 0.85 | ALOX15 (0.52) | LMNAALOX15CYP3A4STAT3MEN1 | |
| SCHEMBL3024189 | 0.83 | ALDH1A1 (0.61) | LMNAALOX15CYP3A4MEN1KMT2A | |
| SCHEMBL17513155 | 0.83 | ALDH1A1 (0.55) | LMNAALOX15MEN1KMT2APTPN1 | |
| (-)-Limonene SCHEMBL17332032 | 0.82 | LMNA (0.61) | LMNAALOX15CYP3A4STAT3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 780 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4444108-B1 | ALDEHYDE MIXTURES FOR FLAVOUR IMPROVEMENT | SYMRISE AG (DE) | 2025-09-10 | — | — | EP | claimed |
| US-20240057595-A1 | INSECT REPELLENT COMPOSITIONS | SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AND COLLATERAL AGENT | 2024-02-22 | — | — | US | claimed |
| US-20240050512-A1 | REDUCTION OF VIRAL INFECTIONS | PHOXBIO LIMITED (IE) | 2024-02-15 | — | — | US | claimed |
| US-20240050393-A1 | COMPOSITIONS AND USES THEREOF FOR TREATING OR PREVENTING VIRAL INFECTIONS | GILVERDI - HEALTH AND BEAUTY LTD (IL) | 2024-02-15 | — | — | US | claimed |
| EP-4161293-B1 | FLAVOURING COMPOSITION WITH BALANCED TASTE PROFILE | SYMRISE AG (DE) | 2024-01-31 | — | — | EP | claimed |
| US-20240002888-A1 | RECOMBINANT MICROORGANISM COMPRISING POLYNUCLEOTIDE ENCODING TARGET PRODUCT BINDING PROTEIN FUSED TO SECRETION SIGNAL SEQUENCE, COMPOSITION COMPRISING SAME, AND METHOD FOR PRODUCING TARGET PRODUCT BY USING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2024-01-04 | — | — | US | claimed |
| WO-2023243534-A1 | METHOD FOR IMPROVING FLAVOR OF LEMON-FLAVORED BEVERAGE | アサヒグループホールディングス株式会社 | 2023-12-21 | — | — | WO | claimed |
| US-11806448-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2023-11-07 | — | — | US | claimed |
| EP-4161291-B1 | FLAVORING COMPOSITIONS FOR TASTE IMPROVEMENT | SYMRISE AG (DE) | 2023-11-01 | — | — | EP | claimed |
| EP-4219533-A1 | RECOMBINANT MICROORGANISM COMPRISING POLYNUCLEOTIDE ENCODING TARGET PRODUCT BINDING PROTEIN FUSED TO SECRETION SIGNAL SEQUENCE, COMPOSITION COMPRISING SAME, AND METHOD FOR PRODUCING TARGET PRODUCT BY USING SAME | Korea Research Institute of Chemical Technology (KR) | 2023-08-02 | — | — | EP | claimed |
| EP-1351678-A2 | TREATMENT FOR INHIBITING NEOPLASTIC LESIONS USING INCENSOLE AND/OR FURANOGERMACRENS | Shanahan-Prendergast, Elizabeth (IE) | 2003-10-15 | — | — | EP | claimed |
| WO-2001001996-A9 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS | UNIV WESTERN AUSTRALIA (AU) | 2002-09-12 | — | — | WO | claimed |
| WO-2002053138-A2 | TREATMENT FOR INHIBITING NEOPLASTIC LESIONS USING INCENSOLE AND/OR FURANOGERMACRENS | SHANAHAN-PRENDERGAST ELISABETH (IE) | 2002-07-11 | — | — | WO | claimed |
| EP-1119257-A2 | A NATURAL AND SAFE ALTERNATIVE TO FUNGICIDES, BACTERIOCIDES, NEMATICIDES AND INSECTICIDES FOR PLANT PROTECTION AND AGAINST HOUSEHOLD PESTS | Auburn University Industrial Programs & Tech Transfer (US) | 2001-08-01 | — | — | EP | claimed |
| WO-2001001996-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS | UNIVERSITY OF WESTERN AUSTRALIA (AU) | 2001-01-11 | — | — | WO | claimed |
| CN-1058369-C | Pest control chemicals against pine wood nematodes | KIORITZ CORP (JP) | 2000-11-15 | — | — | CN | claimed |
| WO-2000021364-A9 | A NATURAL AND SAFE ALTERNATIVE TO FUNGICIDES, BACTERIOCIDES, NEMATICIDES AND INSECTICIDES FOR PLANT PROTECTION AND AGAINST HOUSEHOLD PESTS | UNIV AUBURN (US) | 2000-09-21 | — | — | WO | claimed |
| WO-2000021364-A2 | A NATURAL AND SAFE ALTERNATIVE TO FUNGICIDES, BACTERIOCIDES, NEMATICIDES AND INSECTICIDES FOR PLANT PROTECTION AND AGAINST HOUSEHOLD PESTS | AUBURN UNIVERSITY (US) | 2000-04-20 | — | — | WO | claimed |
| US-5314693-A | Hydroxystilbene compounds | KIORITZ CORPORATION (JP) | 1994-05-24 | — | — | US | claimed |
| CN-1075845-A | The pest control chemicals of antagonism pine wood nematodes | KIORITZ CORP (JP) | 1993-09-08 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240002888-A1 | RECOMBINANT MICROORGANISM COMPRISING POLYNUCLEOTIDE ENCODING TARGET PRODUCT BINDING PROTEIN FUSED TO SECRETION SIGNAL SEQUENCE, COMPOSITION COMPRISING SAME, AND METHOD FOR PRODUCING TARGET PRODUCT BY USING SAME | MRPL21, RNGTT, PNKP | LMNA 4052/4885ALOX15 4223/4885CYP3A4 4606/4885 |
| US-20240050512-A1 | REDUCTION OF VIRAL INFECTIONS | TFRC, ZFR, HAMP | LMNA 4199/4885ALOX15 343/4885CYP3A4 1461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.